BR112021024417A2 - Métodos para remoção de componentes indesejados durante processos cromatográficos de múltiplos estágios - Google Patents

Métodos para remoção de componentes indesejados durante processos cromatográficos de múltiplos estágios

Info

Publication number
BR112021024417A2
BR112021024417A2 BR112021024417A BR112021024417A BR112021024417A2 BR 112021024417 A2 BR112021024417 A2 BR 112021024417A2 BR 112021024417 A BR112021024417 A BR 112021024417A BR 112021024417 A BR112021024417 A BR 112021024417A BR 112021024417 A2 BR112021024417 A2 BR 112021024417A2
Authority
BR
Brazil
Prior art keywords
methods
components during
removing unwanted
unwanted components
affinity
Prior art date
Application number
BR112021024417A
Other languages
English (en)
Inventor
Andrew Tustian
Mark Chiboroski
Travis Tran
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of BR112021024417A2 publication Critical patent/BR112021024417A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B01D15/203—Equilibration or regeneration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

métodos para remoção de componentes indesejados durante processos cromatográficos de múltiplos estágios. a presente invenção refere-se a uma cromatografia de afinidade de alta resolução que combina processos de resolução de afinidade e captura de afinidade com o uso de uma única matriz de cromatografia que resulta em resolução melhorada entre espécies moleculares intimamente relacionadas e aumenta significativamente o rendimento geral do produto para produção comercial em grande escala de proteínas heterodiméricas, tais como anticorpos biespecíficos. além disso, os requisitos de tanque e equipamento são reduzidos por meio da capacidade de reduzir a concentração de sal, enquanto aumenta a pureza e a concentração do produto, sem a necessidade de diluição, ultrafiltração ou diafiltração.
BR112021024417A 2019-06-13 2020-06-12 Métodos para remoção de componentes indesejados durante processos cromatográficos de múltiplos estágios BR112021024417A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962860980P 2019-06-13 2019-06-13
PCT/US2020/037433 WO2020252260A1 (en) 2019-06-13 2020-06-12 Methods for removing undesired components during multistage chromatographic processes

Publications (1)

Publication Number Publication Date
BR112021024417A2 true BR112021024417A2 (pt) 2022-01-18

Family

ID=71608046

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024417A BR112021024417A2 (pt) 2019-06-13 2020-06-12 Métodos para remoção de componentes indesejados durante processos cromatográficos de múltiplos estágios

Country Status (13)

Country Link
US (1) US20220306686A1 (pt)
EP (1) EP3983426A1 (pt)
JP (1) JP2022536470A (pt)
KR (1) KR20220024513A (pt)
CN (1) CN113993879A (pt)
AU (1) AU2020293237A1 (pt)
BR (1) BR112021024417A2 (pt)
CA (1) CA3143024A1 (pt)
EA (1) EA202290040A1 (pt)
IL (1) IL288630A (pt)
MA (1) MA56197A (pt)
MX (1) MX2021015087A (pt)
WO (1) WO2020252260A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
EP2570431A3 (en) * 2007-08-30 2013-05-01 CureDM Group Holdings, LLC Compositions and methods of using proislet peptides and analogs thereof
CN102471378B (zh) 2009-06-26 2014-04-02 瑞泽恩制药公司 容易地分离的具有天然免疫球蛋白形式的双特异性抗体
AR101262A1 (es) * 2014-07-26 2016-12-07 Regeneron Pharma Plataforma de purificación para anticuerpos biespecíficos
GB201602156D0 (en) * 2016-02-05 2016-03-23 Jones Philip C And Boku University Of Natural Resources And Life Sciences Heterodimers and purification thereof

Also Published As

Publication number Publication date
IL288630A (en) 2022-02-01
CA3143024A1 (en) 2020-12-17
EP3983426A1 (en) 2022-04-20
US20220306686A1 (en) 2022-09-29
EA202290040A1 (ru) 2022-03-05
AU2020293237A1 (en) 2022-01-06
CN113993879A (zh) 2022-01-28
KR20220024513A (ko) 2022-03-03
WO2020252260A1 (en) 2020-12-17
MX2021015087A (es) 2022-01-18
MA56197A (fr) 2022-04-20
JP2022536470A (ja) 2022-08-17

Similar Documents

Publication Publication Date Title
BR112018003127A2 (pt) purificação de fkpa e usos do mesmo para produzir polipeptídeos recombinantes
WO2015191911A3 (en) Protein enriched microvesicles and methods of making and using the same
BR112018075516A2 (pt) purificação de anticorpos multiespecíficos
BR112012017124B8 (pt) método para produzir e para purificar um multímero polipeptídico
EP3626726A3 (en) Solid phase peptide synthesis processes and associated systems
WO2015195453A3 (en) Methods for increasing the capacity of flow-through processes
MX2012012119A (es) Produccion de proteinas heteromultimericas.
BR112012024956A2 (pt) processo para a purificação de uma proteína de fator de crescimento
MX2020003798A (es) Metodos para la purificacion de arilsulfatasa a.
BR112016020517A2 (pt) método de produção de lipídeo através da utilização de ss-cetoacil-acp sintase
AR091647A1 (es) Purificacion de iduronato-2-sulfatasa
MX2021001418A (es) Produccion de proteinas heteromultimericas usando celulas de mamifero.
MX2022006759A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
MX2016017115A (es) Metodos y reactivos para la purificacion de proteinas.
MY183011A (en) Novel purification process of gonadotropin
BR112021024417A2 (pt) Métodos para remoção de componentes indesejados durante processos cromatográficos de múltiplos estágios
BR112016023624A2 (pt) proteínas de antiporte prótons/ açúcar tonoplásticas e uso do mesmo para o aumento da concentração de sacarose de um órgão de plantas para armazenamento de sacarose
MX2016002870A (es) Moleculas que contienen fc que presentan perfiles de glicoforma predecibles, consistentes y reproducibles.
WO2018190677A3 (en) METHOD OF PURIFYING ANALOGUE ANTIBODIES USING CATION EXCHANGE CHROMATOGRAPHY
MX2021016092A (es) Metodos de purificacion de proteinas.
PH12017500291A1 (en) Purification of polyphenols
NZ629093A (en) Monoterpene glycosyltransferase originating from hop and method for using same
WO2017089781A3 (en) Peptides derived from abnormal spindle-like microcephaly-associated protein (aspm) and complexes comprising such peptides bound to mhc molecules
BR112021021227A2 (pt) Composições e métodos para a detecção de proteínas
AR100863A1 (es) Un proceso para obtener hmg-up (gonadotropina menopáusica humana con grado de ultrapureza) y una composición libre de contaminantes